The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kim I.V.

FBGU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdravsotsrazvitiia Rossii, Moskva

Bochkareva E.V.

National Medical Research Center of Preventive Medicine, Moscow, Russia

Varakin Yu.Ya.

Research Center of Neurology, Russian Academy of Sciences, Moscow

The unity of approaches to preventing coronary heart disease and cerebrovascular diseases

Authors:

Kim I.V., Bochkareva E.V., Varakin Yu.Ya.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2015;18(6): 24‑33

DOI: 10.17116/profmed201518624-33

Views: 1244

Downloaded: 21

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kim IV, Bochkareva EV, Varakin YuYa. The unity of approaches to preventing coronary heart disease and cerebrovascular diseases. Russian Journal of Preventive Medicine. 2015;18(6):24‑33. (In Russ.)
https://doi.org/10.17116/profmed201518624-33

 
МСФ на ЯМ
Close metadata
Recommended articles:
Prevalence of cardiovascular diseases risk factors in Maga­dan schoolchildren. Russian Journal of Preventive Medi­cine. 2024;(3):39-44
Gender differences in mental and beha­vioural diso­rders as an impo­rtant stage of cardiovascular diseases prevention in young people. Russian Journal of Preventive Medi­cine. 2024;(3):66-71
Colo­rectal cancer: inci­dence, risk factors, and screening. Russian Journal of Preventive Medi­cine. 2024;(3):93-97
Possibilities of cardiometabolic diseases prevention in women with pregnancy adve­rse outcomes in medi­cal history. Russian Journal of Preventive Medi­cine. 2024;(3):98-103
Computed tomo­graphy in diagnosis of coro­nary athe­rosclerosis and its complications. Russian Cardiology Bulletin. 2024;(1):7-15
Coro­nary artery bypass surgery with aortic valve replacement in a patient with hepa­rin-induced thro­mbocytopenia. Russian Cardiology Bulletin. 2024;(1):73-78
Effe­ctiveness of body weight control using remote digi­tal technologies in various orga­nizational models of primary health care. Medi­cal Technologies. Asse­ssment and Choice. 2024;(1):26-36
Ischemic stroke in men 18—50 years of age. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):5-11
The rela­tionship between the deve­lopment of post-stroke cognitive impairment and changes in the coagulation component of hemo­stasis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):23-29
Primary prevention of computer game addi­ction in students of educational institutions. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):97-103

Numerous clinical and epidemiological studies suggesting a close association between coronary heart disease (CHD) and cerebrovascular diseases (CVDs) are reviewed. Information characterizing the unity of approaches to preventing CHD and CVDs is given. The major clinical forms of CVDs and their prognostic value are described in detail. Particular emphasis is placed on the achievements of Russian and foreign investigators in developing and using epidemiological techniques to examine the population, primarily validated CHD and CVD questionnaires. The data given in the review suggest that it is expedient to use screening techniques to identify people at high risk for CHD and CVDs in order to improve the work of outpatient facilities in diagnosing, preventing, and treating circulatory system disorders.

Keywords:

coronary heart disease
cerebrovascular diseases
risk factors
prevention
early detection
unified questionnaire.

Authors:

Kim I.V.

FBGU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdravsotsrazvitiia Rossii, Moskva

Bochkareva E.V.

National Medical Research Center of Preventive Medicine, Moscow, Russia

Varakin Yu.Ya.

Research Center of Neurology, Russian Academy of Sciences, Moscow

List of references:

  1. Shalnova SA, Deev AD. Coronary heart disease in Russia: incidence rate and treatment (according to epidemiological data). Ter arkhiv. 2011;1:7-12. (In Russ.).
  2. National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2012 chart book on cardiovascular, lung, and blood diseases. National Institutes of Health. 2012.
  3. Reis SE, Holubkov R, Conrad Smith AJ. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141:735-741.
  4. Han SH, Bae JH, Holmes DR Jr. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J. 2008;29:1359-1369.
  5. et al. Heart disease: The management for doctors. M. 2006. (In Russ.).
  6. Oganov RG, Lepakhin VK, Fitilev SB, et al. Diagnosis and Therapy of Stable Angina in Russian Federation (International Study ATP -Angina Treatment Pattern). Cardiology. 2003;5:9-15. (In Russ.).
  7. Karpov YuA, Deev AD. The Program ALTERNATIVA - Investigation of Antianginal Efficacy and Tolerability of Coraxan (Ivabradine) and Assessment of Quality of Life of Patients With Stable Angina: Results of an Epidemiological Stage. Cardiology. 2008;5:30-35. (In Russ.).
  8. Vasyuk YuA, Shalnova SA, Shkolnik EL, et al. The PRIMA Study: Trimetazidin in the Treatment of Patients With Stable Angina Pectoris After Myocardial Infarction. Epidemiological and Clinical Phases. Cardiology. 2008;2:10-13. (In Russ.).
  9. Chazova LV, Balavadze MB, Glazunov IS, et al. Detection of ischemic heart disease in preventive survey of 40-59-year-old male population of one the Moscow Region. Cardiology. 1981;2:79-83. (In Russ.).
  10. Kokurina EV, Metelitsa VI, Ostrovskaya TP. Angina of effort as an unfavorable predictive factor. Cardiology. 1987;27:38-42. (In Russ.).
  11. Shalnova SA, Deev AD, Karpov YuA, on behalf of PREMIER Study Working Group. Arterial hypertension and coronary heart disease in real-world cardiology Practice. Cardiovascular Therapy and Prevention. 2006;5(2):73-80. (In Russ.).
  12. Varakin YuYa, Gornostaeva GV, Manvelov LS, et al. Clinical and epidemiological study of the nervous system diseases according to screening of the open population. Annals of clinical and experimental neurology. 2012;6:6-12. (In Russ.).
  13. Varakin YuYa. Epidemiological aspects of prevention of cerebral circulation disorders. Atmosphere. Neuropathology. 2005;2:4-10. (In Russ.).
  14. Kravchenko MA, Varakin YuYa, Kuntsevich GI, et al. Risk factors, cerebrovascular and cardiovascular pathology, revealed by screening of the open population. Articles and abstracts collection of the II National congress "Cardioneurology". Moscow 2012;55-57. (In Russ.).
  15. Likhachev SA, Lushik AV. Epidemiology of initial manifestations of cerebrovascular diseases on the example of a therapeutics department of outpatient clinic of Minsk. Articles and abstracts collection of the II National congress "Cardioneurology". Moscow 2012;55-57. (In Russ.).
  16. The general incidence of adult population of Russia in 2012. Statistical materials, part IV. Tables 3.32, 4.34, 4.36, 4.37, 4.42. Moscow. 2013. (In Russ.).URL: http://www.rosminzdrav.ru/documents/8029-statisticheskaya-informatsiya-2012.
  17. Suslina ZA, Varakin YuYa, Vereshhagin NV. Vascular diseases of a brain. Moscow: Medpress-inform. 2009;352. (In Russ.).
  18. Distribution of number of the persons for the first time recognized as disabled people for the disability reasons in 2000-2010. Russia. Statistical pocketbook 2011. Moscow 2011;274-275. (In Russ.).
  19. Finished document bank: Russian Demographis Annual - 2014. (In Russ.).
  20. Shalnova SA, Konradi AO, Karpov YuA, et al. Cardiovascular mortality in 12 Russian Federation regions - participants of the "Cardiovascular Disease Epidemiology in Russian Regions" study. Russian Journal of Cardiology. 2012;5(97):6-11. (In Russ.).
  21. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
  22. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-123.
  23. Romero JR, Wolf PA. Epidemiology of stroke: legacy of the Framingham heart study. Glob Heart. 2013;8(1):67-75.
  24. Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circulation. 2013;77(8):1923-1932.
  25. Asia pacific cohort studies collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707-716.
  26. Brown DW, Giles WH, Greenlund KJ. Blood pressure parameters and risk of fatal stroke, NHANES II mortality study. Am J Hypertens. 2007;20:334-338.
  27. Zelveian PA, Oschepkova EV, Rogoza AN, et al Prognostic significance of insufficient fall of blood pressure during sleep in mild essential hypertensives. 14-th European congress on sleep research. Journal of sleep research. 1998;7:620.
  28. Prokopovich ME, Varakin YuYa, Oshepkova EV. Acute disorders of cerebral circulation: prognostic factors in essential hypertension. Terapevticheskij arkhiv. 2006;10:14-18. (In Russ.).
  29. The Global burden of metabolic risk factors for chronic diseases collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1,8 million participants. Lancet. 2014;383(9921):970-983.
  30. Gordon T, Castelli WP, Hjortland MC. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med. 1977;62(5):707-714.
  31. Multiple risk factor intervention trial research group: Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490-1500.
  32. Assmann G, Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116(6 Pt 2):1713-1724.
  33. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case - control study. Lancet. 2008;372:224-233.
  34. Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298:776-785.
  35. Nordestgaard BG, Chapman MJ, Ray K. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844-2853.
  36. Gurdasani D, Sjouke B, Tsimikas S, et al. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol. 2012;32(12):3058-3065.
  37. Wu J, Chen S, Zhou Y, et al. Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study. PLoS One. 2013;8(9):e74634.
  38. Okamura T, Kokubo Y, Watanabe M, et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis. 2009;203(2):587-592.
  39. Tanabe N, Iso H, Okada K. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the JALS-ECC. Circ J. 2010;74(7):1346-1356.
  40. Paramsothy P, Knopp RH, Bertoni AG, et al. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010;56(13):1034-1041.
  41. Edwards R. The problem of tobacco smoking. BMJ. 2004;328:217-219.
  42. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003.
  43. Prescott E, Hippe M, Schnohr P. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316:1043-1047.
  44. Wolf PA, D'Agostino RB, Kannel WB. Cigarette smoking as a risk factor for stroke. The Framingham study. JAMA. 1988;259(7):1025-1029.
  45. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298(6676):789-794.
  46. Ali SF, Smith EE, Bhatt DL, et al. Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J Am Heart Assoc. 2013;2(3):e000171.
  47. Cardiovascular prevention. National clinical guidelines. Cardiovascular Therapy and Prevention. 2011;10(6). Appendix 2. 96 p. (In Russ.).
  48. Guidelines for the Primary Prevention of Stroke. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832.
  49. Suslina ZA, Varakin YuYa. Clinical guide to early diagnostics, treatment and prevention of cerebrovascular diseases. Moscow: MEDpress-inform. 2015. (In Russ.).
  50. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236.
  51. Diagnostics and treatment of stable angina pectoris. Russian guidelines. Cardiovascular Therapy and Prevention. 2008;7(6). (In Russ.).
  52. Lawes CM, Bennett DA, Feigin VL. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35:776-785.
  53. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527-1535.
  54. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2748.
  55. Suslina ZA, Fonyakin AV, Geraskina LA. Cardioneurology. Current state and prospects of development. Articles and abstracts collection of the II National congress "Cardioneurology". Moscow. 2012;7-13. (In Russ.).
  56. Antithrombotic trialists' collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71-86.
  57. Antiplatelet treatment in patients with stable atherothrombosis. National clinical guidelines. Moscow: Silicea-Poligraf. 2010;164-188. (In Russ.)
  58. Amarenco P, Goldstein LB, Sillesen H, et al. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010;41(3):426-430.
  59. Scandinavian simvastatin survival study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383-1389.
  60. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):267-1278.
  61. Amarenco P, Bogousslavsky J, Callahan A3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549-559.
  62. Endres M, Laufs U. Discontinuation of statin treatment in stroke patients. Stroke. 2006;37(10):2640-2643.
  63. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). European heart journal. 2012;33(13):1635-1701.
  64. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis. 2008;25:457-507.
  65. Shmonin AA, Krasnov VS, Shmonina IA, et al. Current therapy of chronic cerebrovascular attack. Part 2. Archive of internal medicine. 2014;4(18):4-8. (In Russ.).
  66. National Guidelines of Atrial fibrillation. Guidelines of RSC, RSAS, RACVS. Moscow. 2012. (In Russ.).
  67. Yoo J, Yang JH, Choi BW, et al. The frequency and risk of preclinical coronary artery disease detected using multichannel cardiac computed tomography in patients with ischemic stroke. Cerebrovasc Dis. 2012;33(3):286-294.
  68. Calvet D, Touze E, Varenne O. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation. 2010;121:1623-1629.
  69. Gongora-Rivera F, Labreuche J, Jaramillo A, et al. Autopsy Prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke. 2007;38:1203-1210.
  70. Fonyakin AV, Geraskina LA, Suslina ZA. Heart pathology at various subtypes of ischemic stroke. Clinical medicine. 2002;1:25-28. (In Russ.).
  71. Boytsov SA, Martsevich SYu, Ginzburg NP, et al. Lyubertsy study on mortality rate in patients after cerebral stroke or transient ischemic attack (LIS-2). Design and medical treatment estimation. International Heart and Vascular Disease Journal. 2014;2(2):3-11. (In Russ.).
  72. Boytsov SA, Yakushin SS, Martsevich SYu, et al. Outpatient register of cardiovascular diseases in the Ryazan region (RECVASA): principal tascs, experience of development and first results. Ration Pharmacother Cardiol. 2013;9(1):4-14. (In Russ.).
  73. Shmidt EV. Classification of vascular damages of brain. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 1985;9:1281-1288. (In Russ.).
  74. Andreeva OS, Varakin YuYa, Gornostaeva GV. Hypertonic crises in chronic cerebrovascular disease patients (accordind to epidemiological data). Articles and abstracts collection of the II National congress "Cardioneurology". Moscow. 2012;58-60. (In Russ.).
  75. Bos MJ, Van Rijn MJ, Witteman JC, et al. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877-2885.
  76. Moiseev GF, Shmidt EV, Vereshagin NV, et al. Catamnesis of patient after transient disorders of cerebral circulation. Prevention, new diagnostic methods and treatment of the main nervous disorders. Baku. 1982;4-8. (In Russ.).
  77. Diagnosis and treatment of arterial hypertension. National clinical guidelines. Moscow: Silicea-Poligraf. 2010;504-557. (In Russ.).
  78. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
  79. Mohan KM, Wolfe CD, Rudd AG, et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42(5):1489-1494.
  80. Dhamoon MS, Sciacca RR, Rundek T. Reccurent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006;66:641-646.
  81. Petty GW, Brown RD, Whisnant JP, et al. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50(1):208-216.
  82. Burn J, Dennis M, Bamford J, et al. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke. 1994;25(2):333-337.
  83. Hardie K, Jamrozik K, Hankey GJ, et al. Trends in five-year survival and risk of recurrent stroke after first-ever stroke in the Perth Community Stroke Study. Cerebrovasc Dis. 2005;19(3):179-185.
  84. Touze E, Varenne O, Chatellier G, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36:2748-2755.
  85. Dhamoon MS, Tai W, Boden-Albala B, et al. Risk of myocardial infarction and vascular death after first ischemic stroke. Stroke. 2007;38:1752-1758.
  86. Kokurina EV, Varakin Yu.Ya, Koltunov IE. Active identification and treatment of coronary heart disease and cerebrovascular diseases in practical health care. Moscow. 2009;100. (In Russ.).
  87. Jones WL, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke. 2001;32:2232-2236.
  88. Sung VW, Johnson N, Granstaff US, et al. Sensitivity and specificity of stroke symptom questions to detect stroke or transient ischemic attack. Neuroepidemiology. 2011;36(2):100-104.
  89. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull. Wld Hlth Org. 1962;27:645-658.
  90. Rose GA, Blackburn H. Cardiovascular survey methods. Monogr. Ser. World Health Organ. 1968;56:-188.
  91. Chazova LV, Kalinina AM. Main epidemiological methods of studying of cardiovascular diseases. Resource materials. Moscow. 1993;72 (In Russ.).
  92. Glazunov IS. To method of epidemiological studies in the field of coronary heart disease. Epidemiology of arterial hypertension and coronary atherosclerosis. Articles collection. II Edition. Moscow: Medicine. 1969;33-46. (In Russ.).
  93. Pakhomova EV, Shalnova SA, Chazova LV. The prevalence of a syndrome of angina in combination with ECG changes among men and women of 20-69 years. Abstracts of the IV Republican Conference of Cardiologists of the Estonian SSR. Tallinn. 1983;210-211. (In Russ.).
  94. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
  95. Chazova LV, Balavadze MB, Glazunov IS, et al. Application to mass community examination of a standard WHO questionnaire for recognition of angina pectoris of effort. Terapevticheskij arkhiv. 1981;5:33-38. (In Russ.).
  96. Kim IV, Bochkareva EV, Varakin YuYa, Kokurina EV, Aleksandrova EB. Main results of screening methodology to reveal cardio- and cerebrovascular pathology in primary outpatient care. Cardiovascular Therapy and Prevention. 2014;13(3):25-31. (In Russ.).

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.